SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-033356
Filing Date
2020-02-12
Accepted
2020-02-12 16:55:02
Documents
2
Group Members
JONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d867224dsc13ga.htm SC 13G/A 123907
2 EX-99.B d867224dex99b.htm EX-99.B 9962
  Complete submission text file 0001193125-20-033356.txt   135725
Mailing Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Subject) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90054 | Film No.: 20605038
SIC: 2834 Pharmaceutical Preparations